Share the Video:

A conversation with Carl Hart, Ph.D.

Carl Hart

Carl Hart is the Chair of the Department of Psychology at Columbia University. He is also the Ziff Professor of Psychology in the Departments of Psychology and Psychiatry. Professor Hart has published numerous scientific and popular articles in the area of neuropsychopharmacology and is co-author of the textbook Drugs, Society and Human Behavior (with Charles Ksir). His most recent book, “High Price: A Neuroscientist’s Journey of Self-Discovery That Challenges Everything You Know About Drugs and Society,” was the 2014 winner of the PEN/E.O. Wilson Literary Science Writing Award. Professor Hart has appeared on multiple podcasts, radio and television shows including Real Time with Bill Maher and The O’Reilly Factor. He has also appeared in several documentary films including the award-winning “The House I Live In.” His essays have been published in several popular publications including The New York Times, Scientific American, The Nation, Ebony, The Root, and O Globo (Brazil’s leading newspaper).

Become a MAPS Member with a monthly donation

As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.

What Will People Think? Revealing Public Knowledge, Belief, and Perceptions of Psychedelics

Imran Khan presents findings of the Psychedelic Insight Poll, a national survey by the Berkeley Center for the Science of Psychedelics to understand public perceptions of psychedelic substances. The poll

Imran Khan

PS2023 Business Policy and Advocacy Psychedelic Science Research Research and Science

The state of the psychedelic sector

Hardman provides a quick overview of the emerging psychedelic sector, covering financial, research, and policy landscapes with data visuals. He also explores unanswered questions about the sector's future.

Josh Hardman

PS2023 Policy Policy and Advocacy Psychedelic Science Research Research and Science Social and Cultural

Psychedelic policy approaches: from the visionary to the pragmatic

Discussion between experts on pragmatic frameworks, demographic considerations, and evidence-based practices shaping psychedelic policy reform for diverse contexts, addressing regulatory challenges and fostering nuanced understanding.

Tatiana Quintana, Melissa Lavasani, Logan Davidson

PS2023 Business Health Equity Policy and Advocacy Psychedelic Science Research Research and Science

Innovations in Global Healthcare and Lessons for Psychedelics

Elliot Cohen (Pillpack, Amazon) and Protik Basu (World Bank, UN, Helena) share insights on healthcare delivery, psychedelics industry, scaling challenges, and technology's role in patient care.

Andrew “Mo” Septimus, Protik Basu, Elliot Cohen

PS2023 MDMA Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Research Research and Science

Priorities for the next generation of psychedelic science

NIMH Director Joshua A. Gordon and trauma researcher Barbara O. Rothbaum discuss the current state and future directions of psychedelic research, emphasizing the need for deeper understanding and robust study

Joshua A Gordon

PS2023 Policy and Advocacy Psychedelic Science Public Benefit Research Research and Science

The Opportunities and Challenges for New Psychedelic Researchers to Receive NIH Funding — Heffter Research Institute and International Society for Research on Psychedelics

Heffter Research Institute funds classic psychedelic drug research. Panel advocates for increased funding by Congressional Psychedelics Advancing Clinical Treatments Caucus, emphasizing support for new researchers and ongoing discoveries.

George Greer, Steven Grant, Katrin H. Preller

PS2023 Policy Policy and Advocacy Psychedelic Science Public Benefit Research Research and Science

Updates from leading statewide regulatory initiatives - Colorado

Oregon’s Psilocybin Services Act and Colorado’s Natural Medicine Health Act are pioneering successful statewide initiatives regulating adult psychedelic substance use. Leaders discuss challenges and lessons learned in implementation.

Rev Veronica Lightning Horse P…, Ean Seeb, Hadas Alterman

PS2023 Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Research Research and Science Resources for Therapists

The State of Psychedelic Research Since 2017

Drs. Summergrad and Insel reflect on the progress and remaining questions in psychedelic science since 2017. They delve into topics like efficacy, regulation, therapy, and provider experience.

Paul Summergrad, Tom Insel, Rachel Nuwer

PS2023 Policy Policy and Advocacy Psychedelic Science Public Benefit Research Research and Science

Updates from leading statewide regulatory initiatives - Oregon

Oregon’s Psilocybin Services Act and Colorado’s Natural Medicine Health Act are pioneering successful statewide initiatives regulating adult psychedelic substance use, influencing drug policy reforms in eleven other states in 2023.

Angela E Albee, Sam Chapman

A conversation with Carl Hart, Ph.D.

Become a MAPS Member with a monthly donation

Related Videos